EAPH - Easton Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
Total Revenue
396
Cost of Revenue
437
Gross Profit
-41
Operating Expenses
Research Development
144
Selling General and Administrative
2,886
Total Operating Expenses
3,103
Operating Income or Loss
-3,144
Interest Expense
10
Total Other Income/Expenses Net
695
Income Before Tax
-
Income Tax Expense
-
Income from Continuing Operations
-2,555
Net Income
-2,555
Net Income available to common shareholders
-2,555
Reported EPS
Basic
-
Diluted
-
Weighted average shares outstanding
Basic
-
Diluted
-
EBITDA
-